{name}
{subtitle}
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~61 mi. (Freiburg, Germany, +226 more cities)
facility
Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~61 mi. (Freiburg, Germany, +140 more cities)
facility
Universitaetsklinikum Freiburg ( Site 0199)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~61 mi. (Freiburg, Germany, +93 more cities)
facility
Universitaetsklinikum Freiburg ( Site 0512)
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
city
~61 mi. (Freiburg, Germany, +42 more cities)
facility
Universitaetsklinikum Freiburg /ID# 222791
condition
Chronic Myelomonocytic Leukemia, +3 more conditions
drug
celecoxib, +2 more drugs
drug type
Other, +1 more type
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
city
~61 mi. (Freiburg, Germany, +29 more cities)
facility
Universitaetsklinikum Freiburg /ID# 164206
drug
chemotherapy, +1 more drug
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
city
~61 mi. (Freiburg, Germany, +16 more cities)
facility
Site DE49002
drug
cytarabine, +3 more drugs
drug type
chemotherapy, +2 more types